Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 28, Pages 11390-11395
Publisher
Proceedings of the National Academy of Sciences
Online
2012-06-27
DOI
10.1073/pnas.1208708109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys
- (2012) A Ulu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP
- (2011) B. Inceoglu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance
- (2011) A. Luria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tolerating Diabetes: An Alternative Therapeutic Approach for Diabetic Neuropathy
- (2010) Nigel A Calcutt ASN Neuro
- Epoxygenated Fatty Acids and Soluble Epoxide Hydrolase Inhibition: Novel Mediators of Pain Reduction
- (2010) Karen Wagner et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids
- (2010) Christophe Morisseau et al. JOURNAL OF LIPID RESEARCH
- Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis
- (2010) P. Luo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model
- (2009) Jun-Yan Liu et al. BIOCHEMICAL PHARMACOLOGY
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
- (2009) John D. Imig et al. NATURE REVIEWS DRUG DISCOVERY
- Epoxyeicosanoid signaling in CNS function and disease
- (2009) Jeffrey J. Iliff et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Diabetic neuropathy: Mechanisms to management
- (2008) James L. Edwards et al. PHARMACOLOGY & THERAPEUTICS
- Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways
- (2008) B. Inceoglu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological disruption of calcium channel trafficking by the 2 ligand gabapentin
- (2008) J. Hendrich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Painful Diabetic Neuropathy: Epidemiology, Natural History, Early Diagnosis, and Treatment Options
- (2007) Aristidis Veves et al. PAIN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started